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Summary
The increase in availability of actinobacterial whole
genome sequences has revealed huge numbers of
specialised metabolite biosynthetic gene clusters,
encoding a range of bioactive molecules such as
antibiotics, antifungals, immunosuppressives and
anticancer agents. Yet the majority of these clusters
are not expressed under standard laboratory condi-
tions in rich media. Emerging data from studies of
specialised metabolite biosynthesis suggest that the
diversity of regulatory mechanisms is greater than pre-
viously thought and these act at multiple levels,
through a range of signals such as nutrient limitation,
intercellular signalling and competition with other
organisms. Understanding the regulation and environ-
mental cues that lead to the production of these com-
pounds allows us to identify the role that these
compounds play in their natural habitat as well as pro-
vide tools to exploit this untapped source of special-
ised metabolites for therapeutic uses. Here, we
provide an overview of novel regulatory mechanisms
that act in physiological, global and cluster-specific
regulatory manners on biosynthetic pathways in
Actinobacteria and consider these alongside their eco-
logical and evolutionary implications.
Introduction
Actinobacteria exhibit staggering diversity in terms of
their biosynthetic capability for specialised metabolites
such as antibiotics, antifungals, antihelminthics, anti-
virals and immunosuppressives. The production of
specialised metabolites requires the integration of a
range of environmental and physiological inputs to
ensure appropriate production. The conventional view of
these organisms was that each species was capable of
producing one or two different specialised metabolites
from clusters of coordinately regulated genes on the
chromosome. However, genome sequencing efforts
have revealed that there are a large number of special-
ised metabolite biosynthetic gene clusters (BGCs) in
actinobacterial genomes that encode for the production
of potentially useful metabolites which are not actively
expressed under commonly used laboratory conditions.
Prior to the sequencing of the first Streptomyces
genome sequence, the genus was estimated to have the
potential to produce in the region of 150,000 bioactive
compounds (Watve et al., 2001). The availability of
numerous Streptomyces genome sequences now
suggests that this is a gross underestimation of their
biosynthetic capabilities and that there is still a large
reservoir of untapped bioactive molecules to be discov-
ered from these organisms. These BGCs are the so
called ‘cryptic biosynthetic pathways’, and exploiting
these will require a thorough understanding of the
environmental cues and regulatory mechanisms that
trigger the production of these specialised metabolites.
The majority of Actinobacteria that have extensive
specialised metabolism inhabit competitive and nutrient
limited environments such as soil and sediment, and
these highly structured and dynamic locations comprised
a multitude of diverse microniches in which taxonomi-
cally diverse organisms reside and compete for resour-
ces (Stubbendieck et al., 2016; Behie et al., 2017). It is
a competition in these environments that likely drive the
evolution of these adaptive responses (Vargas-Bautista
et al., 2014; Traxler et al., 2015; Behie et al., 2017). Key
to the adaptive nature of production is the appropriate
and coordinated production of these chemically diverse
compounds, the regulation of which has been the focus
of specialised metabolite research for many years.
The identification of a range of regulatory mechanisms
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indicates that highly elaborate regulatory mechanisms
act at all levels of expression from transcriptional control
through to translational control mechanisms (Chandra
and Chater, 2008). Early work on the direct control of
specialised metabolites identified the pathway-specific
regulator proteins [also known as Cluster Situated Regu-
lators (CSR); Huang et al., 2005] such as ActII-ORF4,
RedD and CdaR (White and Bibb, 1997; Wietzorrek and
Bibb, 1997; Ryding et al., 2002), which were amongst
the first members of the well-studied Streptomyces
antibiotic regulatory protein (SARP) protein family to be
identified (Wietzorrek and Bibb, 1997). Later, the role of
g-butyrolactones was identified as an extracellular signal
for the induction of specialised metabolites (Horinouchi
and Beppu, 1994; Hsiao et al., 2007), which were later
shown to act through cytoplasmic binding proteins to
activate CSRs in a range of Actinobacteria (Sidda and
Corre, 2012). The identification of pleiotropic regulators
of specialised metabolites such as the AfsR (Floriano
and Bibb, 1996) and the AbsA1A2 two component sys-
tem in the well-studied strain Streptomyces coelicolor
(Hutchings et al., 2004; Huang et al., 2005) indicated
that there is a complex multilevel control of biosynthesis.
This also highlighted that these organisms must inte-
grate a number of signals to regulate specialised metab-
olite biosynthesis in an appropriate manner (Horinouchi
et al., 1990; Floriano and Bibb, 1996; Horinouchi, 2003;
Parajuli et al., 2005; Maharjan et al., 2009). This work
has been reviewed extensively by Bibb (2005), Van
Wezel and Mcdowall (2011) and Liu and colleagues
(2013); however, recent work has added greater detail
and new mechanisms of regulation have emerged.
Here, we discuss some new regulatory mechanisms that
add to our burgeoning knowledge of environmental
signal integration and how this affects the regulation of
specialised metabolites. Figure 1 illustrates the complex
range of external and internal factors influencing the
regulation of specialised metabolite production in Actino-
bacteria, particularly focussing on the novel mechanisms
discussed in this review.
Physiological regulation – integrating starvation
signals in to specialised metabolite biosynthesis
The production of specialised metabolites in actinomy-
cetes is tightly regulated. Direct regulation occurs at the
level of the BGC, but it is often in response to the
Fig. 1. Schematic summarising the complex range of external and internal factors influencing the regulation of specialised metabolite
production in Actinobacteria particularly focusing on the novel mechanisms discussed in this review.
A range of external signals can trigger specialised metabolite production either through the direct activation of pathway specific regulators or
indirectly via an intricate network of global regulators and intracellular signalling molecules. The signalling molecules and other regulatory ele-
ments contained in the dotted box are also subject to complex interactions amongst themselves. The outcome of these complex interactions
will determine the activation or repression of secondary metabolite biosynthetic gene clusters.
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producing organism responding to their complex and
changing environment. This is unsurprising as laboratory
studies have shown that the activation of these path-
ways is often at the point when nutrients are becoming
depleted. This offers significant challenges to the pri-
mary metabolism of producing organisms to cope with
maintenance of cellular function and production of costly
specialised metabolites (Schniete et al., 2018). Integrat-
ing physiological signals into the production of special-
ised metabolites ensures that these are only produced
when required and this process is usually coordinated
with the onset of morphological differentiation (Bibb,
2013), thus optimising the use of energy and resources.
For instance, DasR, a GntR-like repressor, responds to
environmental conditions by sensing the levels of the chi-
tin monomer GlcNAc and integrates the regulation of
primary metabolism, development and antibiotic produc-
tion in Actinobacteria. The role of DasR in the genus
Streptomyces has been recently reviewed in Urem and
colleagues (2016). Inorganic phosphate starvation also
triggers the production of several specialised metabolites
in actinomycetes (Nieselt et al., 2010; Allenby et al., 2012;
Martı´n et al., 2017). This activation is in many instances
indirectly mediated by the master response regulator
PhoP via signal transduction cascades, which ultimately
activate pathway-specific regulators (Rodrı´guez-Garcı´a
et al., 2007). Similarly, GlnR, the master response regula-
tor for nitrogen metabolism in actinomycetes, which also
plays an important role in carbon uptake and metabolism
in these organisms (Liao et al., 2015), has been recently
found to directly activate pathway-specific regulators of
specialised metabolites in several actinomycete genera
(Yao et al., 2014; He et al., 2016).
It is important to note that the above global physiologi-
cal master regulators are subject to intricate cross-
regulatory metabolic networks, which have an effect on
the production of specialised metabolites in actinomy-
cetes as recently reviewed by Urem and colleagues
(2016).
A link between guanosine tetraphosphate (ppGpp)
synthesis and the regulation of antibiotic production in
actinomycetes has long been established. ppGpp is a
key intracellular signalling molecule, which links nutrient
starvation sensing with adaptive responses in a wide
range of bacteria including actinomycetes. Under condi-
tions of nitrogen limitation, ppGpp is synthesised by the
ribosome bound protein RelA (Cashel et al., 1996).
Although ppGpp synthesis has been previously
shown to be required for antibiotic production under
conditions of nitrogen limitation at least in S. coelicolor
(Chakraburtty and Bibb, 1997; Hesketh et al., 2001), no
evidence of the direct effect of ppGpp synthesis on the
regulation of a specialised metabolite biosynthetic path-
way had been provided until recently.
In the soil actinomycete Microbispora corallina, ppGpp
synthesis has been shown to activate the complex regula-
tory pathway that leads to the biosynthesis of microbispor-
icin, a potent lantibiotic currently undergoing preclinical
trials. ppGpp is responsible for the activation of transcrip-
tion of mibR, encoding for one of the three regulators in
the microbisporicin gene cluster. MibR in turn leads to the
production of a precursor, which subsequently induces
high levels of production of the mature antibiotic in a feed-
forward regulatory mechanism (Fernandez-Martı´nez et al.,
2015). While microbisporicin is the only confirmed exam-
ple of the direct effect of ppGpp over the regulation of
specialised metabolite biosynthesis, it is speculated that
this newly identified physiological regulatory mechanism is
common amongst other actinomycetes including the pla-
nosporicin producer Planomonospora alba (Sherwood and
Bibb, 2013).
Cross-regulation of biosynthetic gene clusters encoding
for specialised metabolites can also occur when they
share precursors. Secondary metabolism is dependent on
the availability of precursors from primary metabolism.
Primary metabolites from the central carbon metabolism,
which function as building precursors for secondary
metabolites, include oxaloacetate, a-ketoglutarate, glycer-
aldehyde-3-phosphate, glucose-6-phosphate and acetyl-
CoA (Huang et al., 2015; Hiltner et al., 2015). For exam-
ple, acetyl-CoA is a precursor for polyketide biosynthesis,
which can be generated via degradation of triacylglycerols.
Thus, actinomycete species, which degrade storage lipids
at a higher rate, will provide higher levels of acetyl-CoA
and ultimately produce higher levels of specialised polyke-
tide metabolites (Le Marechal et al., 2013) and hence why
oil-based fermentation media are used extensively for
industrial polyketide biosynthesis (Hiltner et al., 2015).
When more than one polyketide is encoded in the genome
of the same strain, it is likely that one of these metabolites
will be produced preferentially. Yang and colleagues
(2017) have recently reported that although spirotoamides
and tautomycetin (TTN) are compounds synthesised by
two distinct type I PKSs, competition for the same pool of
acyl-CoA precursors results in the preferential production
of TTN in Streptomyces griseochromogenes. Deletion of
the positive regulators involved in TTN biosynthesis liber-
ates precursors for the production of spirotoamides. Hence
understanding how precursors are shared by different bio-
synthetic clusters may lead to the generation of strains,
which produce previously undetectable compounds.
Global regulation – coordinating regulation across
the genome and across pathways
Originally identified as a highly conserved regulator of
aerial mycelium formation and of antibiotic production in
S. coelicolor, the autoregulatory protein BldD has been
Regulation of specialised metabolites in Actinobacteria 3
VC 2018 The Authors. Environmental Microbiology published by Society for Applied Microbiology and JohnWiley & Sons Ltd,
Environmental Microbiology Reports, 00, 00–00
shown to play a central role in regulating sporulation
and specialised metabolite production in Streptomyces
(Elliot et al., 1998; 2001; Elliot and Leskiw, 1999; Den
Hengst et al., 2010; Al-Bassam et al., 2014). BldD was
recently shown to act through the binding of the second
messenger c-di-GMP, expanding the number of known
molecules that affect specialised metabolite expression.
In S. coelicolor and Streptomyces venezuelae, BldD
directly represses genes involved in sporulation, indi-
rectly affecting specialised metabolite production through
the regulation of bldA; however, direct control of erythro-
mycin production in Saccharopolyspora erythrea and the
SapB-like lantipeptide AmfS in Streptomyces griseus
has been demonstrated (Ueda et al., 2005; Chng et al.,
2008). It remains to be seen how common second mes-
senger regulation of specialised metabolites is within
streptomycetes; however, emerging work is expanding
the roles for other secondary messengers in Streptomy-
ces such as cAMP in leinamycin biosynthesis and
cyclic-di-AMP control of muralytic enzymes (St-Onge
and Elliot, 2015; Huang et al., 2016; Tschowri, 2016;
St-Onge et al., 2017), suggesting that this will be a
future area of focus in the study of these organisms.
Two component regulatory systems are amongst a
plethora of global regulators that affect transcriptional
responses in streptomycetes, including the production of
specialised metabolites. The highly conserved MtrAB
two component system has long been known to be an
important global regulator in Actinobacteria, coordinating
a range of cellular responses and essential cell division
processes such as DnaA, FtsI, DivIVA and FtsZ in Cory-
nebacterium, Mycobacterium and Streptomyces (Via
et al., 1996; M€oker et al., 2004; Cangelosi et al., 2006;
Hoskisson and Hutchings, 2006; Clark et al., 2013).
Recently, the repertoire of genes controlled by MtrAB
was expanded to include the BGC for the antibiotic
chloramphenicol in S. venezuelae (Som et al., 2017a).
Using ChIP-seq analysis of MtrA, Som and colleagues
(2017a) demonstrated direct binding of the response
regulator MtrA to genes of the chloramphenicol as well
as sharing target genes with other Actinobacteria (such
as dnaA, dnaN, oriC and wblE in Mycobacterium). More-
over, MtrA binds to the promoters of the streptomycetes-
specific cell division genes ssgA and ssgB (Som et al.,
2017a). Interestingly, deleting the sensor kinase, MtrB
resulted in constitutive chloramphenicol production and
a global shift in the metabolome of S. venezuelae.
Expanding these studies to S. coelicolor, the same
authors were able to show direct binding of MtrA
upstream of the CSRs actII-Orf4 and redZ, showing
direct regulation of actinorhodin and undecylprodigiosin
respectively (Som et al., 2017b). These data suggest
that deletion of the sensor kinase MtrB uncouples the
control of morphological and physiological differentiation
in streptomycetes, perhaps through mimicking of an as
yet undetermined environmental signal resulting in the
upregulation of BGCs. This suggests that manipulation
of the MtrAB system could be exploited as a universal
process to unlock the biosynthetic potential of these
organisms through the activation of cryptic biosynthetic
pathways as has also been shown for the AfsQ system
(Daniel-Ivad et al., 2017). The role played by a range of
two component regulatory systems in specialised metab-
olism has expanded enormously in recent years.
Systems such as AfsQ1/Q2 (Ishizuka et al., 1992) and
AbsA1/A2 (Anderson et al., 2001) have been shown to
have direct interactions with metabolic responsive regu-
lators such as GlnR (Wang et al., 2013) and PhoP
(Santos-Beneit et al., 2009; Yao and Ye, 2016) and can
form complete nutrient-sensing specialised metabolite
activating signal transduction pathways (Yao and Ye,
2016). This suggests that there is still much to be
learned about interplay between the complex regulatory
pathways of specialised metabolites and the role of two
component regulators in these signal transduction
pathways.
The genome sequences of Actinobacteria have
revealed a huge and untapped resource of gene clusters
encoding potentially bioactive molecules from a diverse
range of chemical families. Intriguingly, their presence
raises several questions around how these metabolites
are cordinately expressed, given the potential for syner-
gistic and antagonistic activities, and how they may be
activated in response to extracellular and intracellular
signals. Whilst the existence of pleiotropic regulators
affecting expression of multiple BGCs is well known
(Huang et al., 2005), cross-regulation between clusters
has rarely been shown. In Streptomyces clavuligerus,
the b-lactam antibiotic, cephamycin and the b-lactamase
inhibitor, clavulanic acid, are encoded contiguously on
the genome in a ‘supercluster’ (Ward and Hodgson,
1993). Their biosynthesis is controlled in a coordinated
manner by the SARP, CcaR located in the cephamycin
BGC (Perez-Llarena et al., 1997; Alexander and Jensen,
1998; Santamarta et al., 2011). Interestingly, these
molecules have complementary biological activities and
may reflect the evolutionary conservation of their linkage
in a ‘supercluster’. A recent article by McLean and
colleagues (2016) showed coordinate regulation of two
chemically unrelated, nonsynergistic specialised meta-
bolites – antimycin and candicidin. The BGCs for both
metabolites are separated by 9 kb on the chromosome
of S. albus S4, but the authors were able to show that
there were conserved binding sites for the pathways
specific regulator of the candicidin BGC, FscRI directly
upstream of the genes encoding the depsipeptide natu-
ral product antimycin (McLean et al., 2016). FscRI is not
a SARP protein but a PAS-LuxR family regulator, yet
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again extending the paradigm of activator proteins
involved in specialised metabolite biosynthesis; more-
over, one that directly regulates two different natural
products. These data have implications for the produc-
tion of heterologous BGCs in streptomycetes. McLean
and colleagues (2016) showed that heterologous
production of antimycin was only possible when fscRI
was present in trans, implying that the simple approach
of cloning cryptic BGCs for streptomycetes and
expressing the BGC in a heterologous host such as
S. coelicolor (Gomez-Escribano and Bibb, 2011) may
not be as straightforward as first thought and CSRs
from other specialised metabolites may be required
for expression.
Cluster-specific regulation – ECFs as new
mechanisms of cluster specific regulation
Cluster-specific regulation refers to regulatory elements
dedicated to the transcriptional control (either via activa-
tion or via repression) of the particular biosynthetic gene
cluster in which they are located. Traditionally in actino-
mycetes, this type of regulation is conducted by either
transcriptional activators/repressors or two component
regulatory systems (Van Wezel and Mcdowall, 2011; Liu
et al., 2013) normally as part of a signalling cascade
triggered by global or physiological regulators.
The extracytoplasmic function (ECF) sigma factors
are a group of small regulatory proteins normally bound
(when inactive) to a cognate membrane-associated anti-
sigma factor. Once the appropriate inducing signal is
detected, the anti-sigma factor is inactivated either
through modifications, conformational changes or prote-
olysis. This inactivation leads to the release of the ECF
and enables it to be recruited by the RNA polymerase
core enzyme, therefore allowing transcription initiation
from ECF-specific target promoters. Actinomycetes con-
tain a large number of ECF sigma factors within their
genomes compared to other bacterial groups (Staron
et al., 2009; Huang et al., 2015), thus highlighting the
genetic and phenotypic plasticity of these organisms in
terms of survival in complex and changing environ-
ments. ECF sigma factors are usually involved in the
regulation of a wide range of physiological processes
such as transport, secretion and extracytoplasmic and
cytoplasmic stress response (Helmann, 2002). However,
identification of several new biosynthetic clusters from
different Actinobacteria has revealed the presence of
ECF sigma/anti-sigma pairs located within BGCs.
Confirmation of their role as cluster-specific regulators of
specialised metabolites has been recently confirmed.
Antimycins are a family of depsipeptides produced by a
hybrid nonribosomal peptide synthetase/polyketide syn-
thase (NRPS)/PKS) assembly line. The ant biosynthetic
cluster is present in at least 14 species of Streptomyces
(Seipke and Hutchings, 2013), and an orphan ECF sigma
factor, that is, it has no co-encoded anti-sigma factor, is
conserved in all the ant clusters. In S. albus S4, two of
the four operons involved in antimycin production are
directly regulated by the orphan ECF sigma factor AntA
(Seipke et al., 2014).
Cluster-specific ECF sigma factor regulation has also
been established in ribosomally synthesized and post-
translationally modified peptides (RiPPs). For example,
the production of a much less active precursor form of
the lantibiotic microbisporicin in M. corallina is initiated
by ppGpp synthesis (see above). This precursor is then
exported, and once outside the cell, it triggers the
release of the cluster specific ECF sigma factor MibX
from the membrane-associated anti-sigma factor MibW.
MibX can now activate transcription of the whole
biosynthetic cluster to reach high levels of production of
the fully modified and active form of microbisporicin
(Foulston and Bibb, 2010; 2011; Fernandez-Martı´nez
et al., 2015). Similarly, production of the lantibiotic plano-
sporicin in P. alba is controlled by a cluster-specific ECF
sigma factor (PspX). In this case, planosporicin itself is
responsible for the release of the sigma factor to acti-
vate transcription of the biosynthetic cluster (Sherwood
and Bibb, 2013). High levels of production of cinnamy-
cin, a lantibiotic produced by Streptomyces cinnamo-
neus, are triggered by low levels of extracellular
cinnamycin, but in this instance, it is a two-component
regulatory system, CinKR, responsible for the transcrip-
tional activation of the biosynthetic cluster (O’rourke
et al., 2017). In all three above cases, this feed-forward
regulatory mechanism seems to function to ensure that
high levels of production of these compounds only
occurs when immunity is already established in the
population. This newly discovered way of regulating anti-
biotic production is likely to serve to coordinate the pro-
duction of the compound throughout the whole mycelial
population with a dual role: production of ecologically
effective levels of the specialised metabolite as well as
ensuring immunity amongst the whole colony.
Concluding remarks: ecological and evolutionary
implications of regulation
Given that the specialised metabolite producing Actino-
bacteria are a widely distributed group of organisms that
occupy a wide range of environmental niches with an
enormous repertoire of specialised metabolites, it is
unsurprising that they have also evolved a vast array of
mechanisms with which to coordinate and regulate the
expression of molecules with adaptive function. The
biosynthesis of specialised metabolites clearly has a
larger evolutionary cost to the producing strain than
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carrying the resistance mechanism to a specialised
metabolite where tens of kilobases of DNA are required
to encode BGCs whereas only hundreds of bases are
required for many resistance mechanisms (Traxler et al.,
2015). Therefore, the energetic cost to produce the
mRNA, translate the protein and utilise the primary
metabolic building blocks to produce even the most
modest chemical scaffold of a specialised metabolite
must be large, especially in an environment where
nutrients are becoming limited. The evolutionary strategy
that these organisms have evolved is to tightly regulate
and coordinate production of these costly metabolites to
ensure that their production is timely and appropriate.
Moreover, the incorporation of systems for the synchro-
nisation of immunity mechanisms to ensure protection of
the whole multicellular population is now being identified
with increasing frequency. The discovery of the enor-
mous array of signalling molecules, regulatory proteins,
regulatory networks and pathways in Actinobacteria has
shown that evolution has solved the problem in many
different ways, and undoubtedly, there are novel
mechanisms still to be elucidated, such as the recently
discovered novel LmbU family of CSRs, which appears
to be widespread in BGCs of Actinobacteria (Hou et al.,
2018).
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